Adonis Phytoceuticals Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 18-07-2024
- Paid Up Capital ₹ 0.10 M
as on 18-07-2024
- Company Age 11 Year, 7 Months
- Last Filing with ROC 31 Mar 2023
- Revenue 29.37%
(FY 2023)
- Profit -17.94%
(FY 2023)
- Ebitda 784.00%
(FY 2023)
- Net Worth 35.61%
(FY 2023)
- Total Assets 49.43%
(FY 2023)
About Adonis Phytoceuticals
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Gurcharan Singh, Tajinder Singh, and Jagjit Singh serve as directors at the Company.
- CIN/LLPIN
U24233DL2013PTC252019
- Company No.
252019
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
14 May 2013
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
New Dehi, Delhi, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Adonis Phytoceuticals Private Limited offer?
Adonis Phytoceuticals Private Limited offers a wide range of products and services, including Hair Care, Shampoo, Health Conditions, Kidney Care, Hair Growth Supplements.
Who are the key members and board of directors at Adonis Phytoceuticals?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Gurcharan Singh  | Director | 06-Aug-2014 | Current |
| Tajinder Singh | Director | 14-May-2013 | Current |
| Jagjit Singh | Additional Director | Current |
Financial Performance of Adonis Phytoceuticals.
Adonis Phytoceuticals Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 29.37% increase. The company also saw a substantial fall in profitability, with a 17.94% decrease in profit. The company's net worth Soared by an impressive increase of 35.61%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Adonis Phytoceuticals?
In 2023, Adonis Phytoceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Helios International Healthcare Private LimitedActive 11 years 6 monthsTajinder Singh is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Adonis Phytoceuticals?
Adonis Phytoceuticals has a workforce of 28 employees as of Apr 09, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Adonis Phytoceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Adonis Phytoceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
